Chemokines and glial cells: A complex network in the central nervous system

Neurochemical Research

Volumn 29, Issue 5, 2004, Pages 1017-1038

  Ambrosini, Elena ^a   Aloisi, Francesca ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Astrocytes; Chemokines; Glial activation; Inflammation; Microglia; Neurodegeneration; Oligodendrocytes

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CX3C CHEMOKINE; FRACTALKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; JANUS KINASE; LYMPHOCYTE ANTIGEN RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; PROTEIN TYROSINE PHOSPHATASE; RANTES; STAT PROTEIN; STROMAL CELL DERIVED FACTOR 1; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ASTROCYTE; BRAIN TUMOR; CELL SUBPOPULATION; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; ENCEPHALITIS; GLIA CELL; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; INFLAMMATION; ISCHEMIA; LEUKOCYTE; LYMPHOID TISSUE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL; NERVE CELL NETWORK; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM FUNCTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MOTIF; REVIEW; ANIMAL; BIOSYNTHESIS; CYTOLOGY; GLIA; METABOLISM; PHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; JANUS;

ANIMALS; CENTRAL NERVOUS SYSTEM; CHEMOKINES; HUMANS; NEUROGLIA; RECEPTORS, CHEMOKINE;

EID: 3142729054     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000021246.96864.89     Document Type: Review

References (239)

1. Rossi, D. and Zlotnik, A. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:217-242.
2. IUIS/WHO Subcommittee on Chemokine Nomenclature. Chemokine/chemokine receptor nomenclature. J. Interf. Cyto. Res. 22:1067-1068.
3. Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., and Strieter, R. M. 2000. CXC chemokines in angiogenesis. J. Leukoc. Biol. 68:1-8.
4. Horuk, R. 1999. Chemokine receptors and HIV-1: the fusion of two major research fields. Immunol. Today 20:89-94.
5. Murphy, P. M. 2000. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat. Immunol. 2:116-122.
6. Alcami, A. 2003. Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 3:36-50.
7. Gerard, C. and Rollins, B. J. 2001. Chemokines and disease. Nat. Immunol. 2:108-115.
8. Proudfoot, A. E., Power, C. A., Rommel, C., and Wells, T. N. 2003. Strategies for chemokine antagonists as therapeutics. Semin. Immunol. 15:57-65.
9. Rollins, B. J. 1997. Chemokines. Blood 90:909-928.
10. Mantovani, A. 1999. The chemokine system: redundancy for robust outputs. Immunol. Today 20:254-257.
11. Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., and Schall, T. I. 1997. A new class of membrane-bound chemokine with a CX(3)C motif. Nature 385:640-644.
12. Bajetto, A., Bonavia, R., Barbero, S., and Schettini, G. 2002. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J. Neurochem. 82:1311-1329.
13. Thelen, M. 2001. Dancing to the tune of chemokines. Nat. Immunol. 2:129-134.
14. Mellado, M., Rodriguez-frade, J. M., Aragay, A., DeIreal, G., Martin, A. M., Vilacoro, A. J., Serrano, A., Mayor, F., and Martineza, C. 1998. The chemokine monocyte chemotactic protein 1 triggers Janus kinase 2 activation and tyrosine phosphorylation of the CCR2B receptor. J. Immunol. 161:805-813.
15. Ganju, R. K., Brubaker, S. A., Chernock, R. D., Avraham, S., and Groopman, J. E. 2000. β-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk. J. Biol. Chem. 275:17263-17268.
16. Ransohoff, R. M., Hamilton, T. A., Tani, M., Stoler, M. H., Shick, H. E., Major, J. A., Estes, M. L., Thomas, D. M., and Tuohy, V. K. 1993. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7:592-600.
17. Hulkower, K., Brosnan, C. F., Aquino, D. A., Cammer, W., Kulshrestha, S., Guida, M. P., Rapoport, D. A., and Berman, J. W. 1993. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J. Immunol. 150:2525-2533.
18. Aloisi, F., Carè, A., Borsellino, G., Gallo, P., Rosa, S., Bassani, A., Cabibbo, A., Testa, U., Levi, G., and Peschle, C. 1992. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J. Immunol. 149:2358-2366.
19. Vanguri, P. and Farber, J. M. 1994. IFN and virus-inducible expression of an immediate early gene, crg-2/IP-10, and a delayed gene, I-A alpha in astrocytes and microglia. J. Immunol. 15:1411-1408.
20. Ransohoff, R. M. 1999. Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines. J. Neuroimmunol. 98:57-68.
21. Asensio, V. C. and Campbell, I. L. 1999. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci. 22:504-12.
22. Glabinski, A. R. and Ransohoff, R. M. 1999. Chemokines and chemokine receptors in CNS pathology. J. Neurovirol. 5:3-12.
23. Bajetto, A., Bonavia, R., Barbero, S., Florio, T., and Schettini, G. 2001. Chemokines and their receptors in the central nervous system. Front. Neuroendocrinol. 22:147-184.
24. Biber, K., Zuurman, M. W., Dijkstra, I. M., and Boddeke, H. W. 2002. Chemokines in the brain: neuroimmunology and beyond. Curr. Opin. Pharmacol. 2:63-68.
25. Cho, C. and Miller, R. J. 2002. Chemokine receptors and neural function. J. Neurovirol. 8:573-584.
26. Rezaie, P., Trillo-Pazos, G., Everall, I. P., and Male, D. K. 2002. Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS. Glia 37:64-75.
27. Robinson, S., Tani, M., Strieter, R. M., Ransohoff, R. M., and Miller, R. H. 1998. The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J. Neurosci. 18:10457-10463.
28. Filipovic, R., Jacovcevski, I., and Zecevic, N. 2003. GRO-alpha and CXCR2 in the human fetal brain and multiple sclerosis lesions. Dev. Neurosci. 25:279-290.
29. Tsai, H. H., Frost, E., To, V., Robinson, S., Ffrench-Constant, C., Geertman, R., Ransohoff, R. M., and Miller, R. H. 2002. The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell 110:373-383.
30. Ohtani, Y., Minami, M., Kawaguchi, N., Nishiyori, A., Yamamoto, J., Takami, S., and Satoh, M. 1998. Expression of stromal cell-derived factor-1 and CXCR4 chemokine receptor mRNAs in cultured rat glial and neuronal cells. Neurosci. Lett. 249:163-166.
31. Lazarini, F., Tham, T. N., Casanova, P., Arenzana-Seisdedos, F., and Dubois-Dalcq, M. 2003. Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia 42:139-148.
32. Rostasy, K., Egles, C., Chauhan, A., Kneissl, M., Bahrani, P., Yiannoutsos, C., Hunter, D. D., Nath, A., Hedreen, J. C., and Navia, B. A. 2003. SDF-1 alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study. J. Neuropathol. Exp. Neurol. 62:617-626.
33. Shirozu, M., Nakano, T., Inazawa, J., Tashiro, K., Tada, H., Shinohara, T., and Honjo, T. 1995. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28:495-500.
34. Gleichmann, M., Gillen, C., Czardybon, M., Bosse, F., Greiner-Petter, R., Auer, J., and Muller, H. W. 2000. Cloning and characterization of SDF-1 gamma a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system. Eur. J. Neurosci. 12:1857-1866.
35. Tham, T. N., Lazarini, F., Franceschini, I. A., Lachapelle, F., Amara, A., and Dubois-Dalcq, M. 2001. Developmental pattern of expression of the alpha chemokine stromal cell-derived factor 1 in the rat central nervous system. Eur. J. Neurosci. 13:845-856.
36. Ma, Q., Jones, D., Borghesani, P. R., Segal, R. A., Nagasawa, T., Kishimoto, T., Bronson, R. T., and Springer, T. A. 1998. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 95:9448-9453.
37. Lu, M., Grove, E. A., and Miller, R. J. 2002. Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc. Natl. Acad. Sci. U. S. A. 99:7090-7095.
38. Bagri, A., Gurney, T., He, X. P., Zou, Y. R., Littman, D. R., Tessier-Lavigne, M., and Pleasure, S. J. 2002. The chemokine SDF1 regulates migration of dentate granule cells. Development 129:4249-4260.
39. Xiang, Y., Li, Y., Zhang, Z., Cui, K., Wang, S., Yuan, X. B., Wu, C. P., Poo, M. M., and Duan, S. M. 2002. Nerve growth cone guidance mediated by G protein-coupled receptors. Nat. Neurosci. 5:843-848.
40. Chalasani, S. H., Baribaud, F., Coughlan, C. M., Sunshine, M. J., Lee, V. M. Y., Doms, R. W., Littman, D. R., and Raper, J. A. 2003. The chemokine stromal cell-derived factor-1 promotes the survival of embryonic retinal ganglion cells. J. Neurosci. 23:4601-4612.
41. Arakawa, Y., Bito, H., Furuyashiki, T., Tsuji, T., Takemoto-Kimura, S., Kimura, K., Nozaki, K., Hashimoto, N., and Narumiya, S. 2003. Control of axon elongation via an SDF-1 alpha/Rho/mDia pathway in cultured cerebellar granule neurons. J. Cell Biol. 161:381-391.
42. Vlahakis, S. R., Villasis-Keever, A., Gomez, T., Vanegas, M., Vlahakis, N., and Paya C. V. 2002. G protein-coupled chemokine receptors induce both survival and apoptotic signaling pathways. J. Immunol. 169:5546-5554.
43. Bajetto, A., Barbero, S., Bonavia, R., Piccioli, P., Pirani, P., Florio, T., and Schettini, G. 2001. Stromal cell-derived factor-1 alpha induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1/2 pathway. J. Neurochem. 77:1226-1236.
44. Pan, Y., Lloyd, C., Zhou, H., Dolich, S., Deeds, J., Gonzalo, J. A., Vath, J., Gosselin, M., Ma, J., Dussault, B., Woolf, E., Alperin, G., Culpepper, J., Gutierrez-Ramos, J. C., and Gearing, D. 1997. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387:611-617.
45. Nishiyori, A., Minami, M., Ohtani, Y., Takami, S., Yamamoto, J., Kawaguchi, N., Kume, T., Akaike, A., and Satoh, M. 1998. Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett. 429:167-172.
46. Meucci, O., Fatatis, A., Simen, A. A., and Miller, R. J. 2000. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. USA 97:8075-8080.
47. Hatori, K., Nagai, A., Heisel, R., Ryu, J. K., and Kim, S. U. 2002. Fractalkine and fractalkine receptors in human neurons and glial cells. J. Neurosci. Res. 69:418-426.
48. Harrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., Botti, P., Bacon, K. B., and Feng, L. 1998. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. USA 95:10896-10901.
49. Maciejewski-Lenoir, D., Chen, S., Feng, L., Maki, R., and Bacon, K. B. 1999. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J. Immunol. 163:1628-1635.
50. Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., and Littman, D. R. 2000. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20:4106-4114.
51. Cook, D. N., Chen, S. C., Sullivan, L. M., Manfra, D. J., Wiekowski, M. T., Prosser, D. M., Vassileva, G., and Lira, S. A. 2001. Generation and analysis of mice lacking the chemokine fractalkine. Mol. Cell. Biol. 21:3159-3165.
52. Rezaie, P. and Male, D. 1999. Colonization of the developing human brain and spinal cord by microglia: a review. Microsc. Res. Tech. 45:359-382.
53. Lawson, L. J., Perry, V. H., and Gordon, S. 1992. Turnover of resident microglia in the normal adult mouse brain. Neuroscience 48:405-415.
54. Bakhiet, M., Tjernlund, A., Mousa, A., Gad, A., Stromblad, S., Kuziel, W. A., Seiger, A., and Andersson, J. 2001. RANTES promotes growth and survival of human first-trimester forebrain astrocytes. Nat. Cell Biol. 3:150-157.
55. Giovannelli, A., Limatola, C., Ragozzino, D., Mileo, A. M., Ruggieri, A., Ciotti, M. T., Mercanti, D., Santoni, A., and Eusebi, F. 1998. CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum. J. Neuroimmunol. 92:122-132.
56. Limatola, C., Giovannelli, A., Maggi, L., Ragozzino, D., Castellani, L., Ciotti, M. T., Vacca, F., Mercanti, D., Santoni, A., and Eusebi F. 2000. SDF-1alpha-mediated modulation of synaptic transmission in rat cerebellum. Eur. J. Neurosci. 12:2497-2504.
57. Meucci, O., Fatatis, A., Simen, A. A., Bushell, T. J., Gray, P. W., and Miller, R. J. 1998. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA 95:14500-14505.
58. Puma, C., Danik, M., Quirion, R., Ramon, F., and Williams, S. 2001. The chemokine interleukin-8 acutely reduces Ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. J. Neurochem. 78:960-971.
59. Oh, S. B., Endoh, T., Simen, A. A., Ren, D., and Miller, R. J. 2002. Regulation of calcium currents by chemokines and their receptors. J. Neuroimmunol. 123:66-75.
60. Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J., and Volterra, A. 2001. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4:702-710.
61. Middleton, J., Patterson, A. M., Gardner, L., Schmutz, C., and Ashton, B. A. 2002. Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood 100:3853-3860.
62. Horuk, R., Martin, A., Hesselgesser, J., Hadley, T., Lu, Z. H., Wang, Z. X., and Peiper, S. C. 1996. The Duffy antigen receptor for chemokines: structural analysis and expression in the brain. J. Leukoc. Biol. 59:29-38.
63. Butcher, E. C., Williams, M., Youngman, K., Rott, L., and Briskin, M. 1999. Lymphocyte trafficking and regional immunity. Adv. Immunol. 72:209-253.
64. Laudanna, C., Kim, J. Y., Constantin, G., and Butcher, E. 2002. Rapid leukocyte integrin activation by chemokines. Immunol. Rev. 186:37-46.
65. Piccio, L., Rossi, B., Scarpini, E., Laudanna, C., Giagulli, C., Issekutz, A. C., Vestweber, D., Butcher, E. C., and Constantin, G. 2002. Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors. J. Immunol. 168:1940-1949.
66. Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., and Karin, N. 1992. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356:63-66.
67. Kim, J. S., Gautam, S. C., Chopp, M., Zaloga, C., Jones, M. L., Ward, P. A., and Welch, K. M. 1995. Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat. J. Neuroimmunol. 56:127-134.
68. Andjelkovic, A. V., Spencer, D. D., and Pachter, J. S. 1999. Visualization of chemokine binding sites on human brain microvessels. J. Cell Biol. 145:403-12.
69. Glabinski, A. R. and Ransohoff, R. M. 1999. Sentries at the gate: chemokines and the blood-brain barrier. J. Neurovirol. 5:623-634.
70. Shukaliak, J. A. and Dorovini-Zis, K. 2000. Expression of the beta-chemokines RANTES and MIP-1 beta by human brain microvessel endothelial cells in primary culture. J. Neuropathol. Exp. Neurol. 59:339-352.
71. Alt, C., Laschinger, M., and Engelhardt, B. 2002. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 32:2133-2144.
72. Murphy, C. A., Hoek, R. M., Wiekowski, M. T., Lira, S. A., and Sedgwick, J. D. 2002. Interactions between hemopoietically derived TNF and central nervous system-resident glial chemokines underlie initiation of autoimmune inflammation in the brain. J. Immunol. 169:7054-7062.
73. Jiang, Y., Salafranca, M. N., Adhikari, S., Xia, Y., Feng, L., Sonntag, M. K., deFiebre, C. M., Pennell, N. A., Streit, W. J., and Harrison, J. K. 1998. Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis. J. Neuroimmunol. 86:1-12.
74. Bajetto, A., Bonavia, R., Barbero, S., Piccioli, P., Costa, A., Florio, T., and Schettini, G. 1999. Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J. Neurochem. 73:2348-2357.
75. Odemis, V., Moepps, B., Gierschik, P., and Engele, J. 2002. Interleukin-6 and cAMP induce stromal cell-derived factor-1 chemotaxis in astroglia by up-regulating CXCR4 cell surface expression. Implications for brain inflammation. J. Biol. Chem. 277:39801-39808.
76. Han, Y., He, T., Huang, D. R., Pardo, C. A., and Ransohoff, R. M. 2001. TNF-alpha mediates SDF-1 alpha-induced NF-kappa B activation and cytotoxic effects in primary astrocytes. J. Clin. Invest. 108:425-435.
77. Han, Y., Wang, J., He, T., and Ransohoff, R. M. 2001. TNF-alpha down-regulates CXCR4 expression in primary murine astrocytes. Brain Res. 888:1-10.
78. Barbero, S., Bonavia, R., Bajetto, A., Porcile, C., Pirani, P., Ravetti, J. L., Zona, G. L., Spaziante, R., Florio, T., and Schettini, G. 2003. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res. 63:1969-1974.
79. Pereira, C. F., Middel, J., Jansen, G., Verhoef, J., and Nottet, H. S. 2001. Enhanced expression of fractalkine in HIV-1 associated dementia. J. Neuroimmunol. 115:168-175.
80. Hughes, P. M., Botham, M. S., Frentzel, S., Mir, A., and Perry, V. H. 2002. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 37:314-327.
81. Erichsen, D., Lopez, A. L., Peng, H., Niemann, D., Williams, C., Bauer, M., Morgello, S., Cotter, R. L., Ryan, L. A., Ghorpade, A., Gendelman, H. E., and Zheng, J. 2003. Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia. J. Neuroimmunol. 138:144-155.
82. Yoshida, H., Imaizumi, T., Fujimoto, K., Matsuo, N., Kimura, K., Cui, X. F., Matsumiya, T., Tanji, K., Shibata, T., Tamo, W., Kumagai, M., and Satoh, K. 2001. Synergistic stimulation, by tumor necrosis factor-alpha and interferon-gamma, of fractalkine expression in human astrocytes. Neurosci. Lett. 303:132-136.
83. Glabinski, A. R., Tani, M., Strieter, R. M., Tuohy, V. K., and Ransohoff, R. M. 1997. Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am. J. Pathol. 150:617-630.
84. Nygardas, P. T., Maatta, J. A., and Hinkkanen, A. E. 2000. Chemokine expression by central nervous system resident cells and infiltrating neutrophils during experimental autoimmune encephalomyelitis in the BALB/c mouse. Eur. J. Immunol. 30:1911-1918.
85. Janabi, N., Hau, I., and Tardieu, M. 1999. Negative feedback between prostaglandin and alpha- and beta-chemokine synthesis in human microglial cells and astrocytes. J. Immunol. 162:1701-1706.
86. Kielian, T., Barry, B., and Hickey, W. F. 2001. CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses. J. Immunol. 166:4634-4643.
87. Luo, Y., Fischer, F. R., Hancock, W. W., and Dorf, M. E. 2000. Macrophage inflammatory protein-2 and KC induce chemokine production by mouse astrocytes. J. Immunol. 165:4015-4023.
88. Luo, Y., Berman, M. A., Zhai, Q. W., Fischer, F. R., Abromson-Leeman, S. R., Zhang, Y., Kuziel, W. A., Gerard, C., and Dorf, M. E. 2002. RANTES stimulates inflammatory cascades and receptor modulation in murine astrocytes. Glia 39:19-30.
89. Otto, V. I., Gloor, S. M., Frentzel, S., Gilli, U., Ammann, E., Hein, A. E., Folkers, G., Trentz, O., Kossmann, T., and Morganti-Kossmann, M. C. 2002. The production of macrophage inflammatory protein-2 induced by soluble intercellular adhesion molecule-1 in mouse astrocytes is mediated by SRC tyrosine kinases and p42/44 mitogen-activated protein kinase. J. Neurochem. 80:824-834.
90. Oh, J. W., Schwiebert, L. M., and Benveniste, E. N. 1999. Cytokine regulation of CC and CXC chemokine expression by human astrocytes. J. Neurovirol. 5:82-94.
91. Cota, M., Kleinschmidt, A., Ceccherini-Silberstein, F., Aloisi, F., Mengozzi, M., Mantovani, A., Brack-Werner, R., and Poli, G. 2000. Upregulated expression of interleukin-8, RANTES and chemokine receptors in human astrocytic cells infected with HIV-1. J. Neurovirol. 6:75-83.
92. Kutsch, O., Oh, J., Nath, A., and Benveniste, E. N. 2000. Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J. Virol. 74:9214-9221.
93. Cheeran, M. C., Hu, S., Yager, S. L., Gekker, G., Peterson, P. K. and Lokensgard, J. R. 2001. Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications. J. Neurovirol. 7:135-147.
94. Jauneau, A. C., Ischenko, A., Chan, P., and Fontaine, M. 2003. Complement component anaphylatoxins upregulate chemokine expression by human astrocytes. FEBS Lett. 537:17-22.
95. Guillemin, G. J., Croitoru-Lamoury, J., Dormont, D., Armati, P. J., and Brew, B. J. 2003. Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes. Glia 41:371-81.
96. Croitoru-Lamoury, J., Guillemin, G. J., Boussin, F. D., Mognetti, B., Gigout, L. I., Cheret, A., Vaslin, B., Le Grand, R., Brew, B. J., and Dormont, D. 2003. Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation. Glia 41:354-370.
97. Flynn, G., Maru, S., Loughlin, J., Romero, I. A., and Male, D. 2003. Regulation of chemokine receptor expression in human microglia and astrocytes. J. Neuroimmunol. 136:84-93.
98. Heesen, M., Tanabe, S., Berman, M. A., Yoshizawa, I., Luo, Y., Kim R. J., Post, T. W., Gerard, C., and Dorf, M. E. 1996. Mouse astrocytes respond to the chemokines MCP-1 and KC, but reverse transcriptase-polymerase chain reaction does not detect mRNA for the KC or new MCP-1 receptor. J. Neurosci. Res. 45:382-391.
99. Tani, M., Glabinski, A. R., Tuohy, V. K., Stoler, M. H., Estes, M. L., and Ransohoff, R. M. 1996. In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am. J. Pathol. 148:889-896.
100. Hesselgesser, J. and Horuk, R. 1999. Chemokine and chemokine receptor expression in the central nervous system. J. Neurovirol. 5:13-26.
101. Sorensen, T. L., Tani, M., Jensen, J., Pierce, V., Lucchinetti, C., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F., Strieter, R. M., Frederiksen, J. E., and Ransohoff, R. M. 1999. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103:807-815.
102. Balashov, K. E., Rottman, J. B., Weiner, H. L., and Hancock W. W. 1999. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. U. S. A. 96:6873-6878.
103. Simpson, J. E., Newcombe, J., Cuzner, M. L., and Woodroofe, M. N. 2000. Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol. Appl. Neurobiol. 26:133-142.
104. Lane, T. E., Asensio, V. C., Yu. N., Paoletti, A. D., Campbell, I. L., and Buchmeier, M. J. 1998. Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J. Immunol. 160:970-978.
105. Sauder, C., Hallensleben, W., Pagenstecher, A., Schneckenburger, S., Biro, L., Pertlik, D., Hausmann, J., Suter, M., and Staeheli, P. 2000. Chemokine gene expression in astrocytes of Borna disease virus-infected rats and mice in the absence of inflammation. J. Virol. 74:9267-9280.
106. Strack, A., Asensio, V. C., Campbell, I. L., Schluter, D., and Deckert, M. 2002. Chemokines are differentially expressed by astrocytes, microglia and inflammatory leukocytes in Toxoplasma encephalitis and critically regulated by interferon-gamma. Acta Neuropathol. (Berlin) 103:458-468.
107. Liu, M. T., Chen, B. P., Oertel, P., Buchmeier, M. J., Armstrong, D., Hamilton, T. A., and Lane, T. E. 2000. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J. Immunol. 165:2327-2330.
108. Fisher, S. N., Vanguri, P., Shin, H. S., and Shin, M. L. 1995. Regulatory mechanisms of murantes and CRG-2 chemokine gene induction in central nervous system glial cells by virus. Brain Behav. Immun. 9:331-344.
109. Cole, K. E., Strick, C. A., Paradis, T. J., Ogborne, K. T., Loetscher, M., Gladue, R. P., Lin, W., Boyd, J. G., Moser, B., Wood, D. E., Sahagan, B. G., and Neote, K. 1998. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 187:2009-2021.
110. Hua, L. L. and Lee, S. C. 2000. Distinct patterns of stimulus-inducible chemokine mRNA accumulation in human fetal astrocytes and microglia. Glia 30:74-81.
111. Asensio, V. C., Maier, J., Milner, R., Boztug, K., Kincaid, C., Moulard, M., Phillipson, C., Lindsley, K., Krucker, T., Fox, H. S., and Campbell, I. L. 2001. Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J. Virol. 75:7067-7077.
112. Palma, J. P. and Kim, B. S. 2001. Induction of selected chemokines in glial cells infected with Theiler's virus. J. Neuroimmunol. 117:166-170.
113. Salmaggi, A., Gelati, M., Dufour, A., Corsini, E., Pagano, S., Baccalini, R., Ferrero, E., Scabini, S., Silei, V., Ciusani, E., and De Rossi, M. 2002. Expression and modulation of IFN-gamma-inducible chemokines (IP-10, Mig, and I-TAC) in human brain endothelium and astrocytes: possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis. J. Interferon Cytokine Res. 22:631-640.
114. Biber, K., Dijkstra, I., Trebst, C., De Groot, C. J., Ransohoff, R. M., and Boddeke, H. W. 2002. Functional expression of CXCR3 in cultured mouse and human astrocytes and microglia. Neuroscience 112:487-497.
115. Calvo, C. F., Yoshimura, T., Gelman, M., and Mallat, M. 1996. Production of monocyte chemotactic protein-1 by rat brain macrophages. Eur. J. Neurosci. 8:1725-1734.
116. Gourmala, N. G., Buttini, M., Limonta, S., Sauter, A., and Boddeke, H. W. 1997. Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration. J. Neuroimmunol. 74:35-44.
117. Glabinski, A. R., Balasingam, V., Tani, M., Kunkel, S. L., Strieter, R. M., Yong, V. W., and Ransohoff, R. M. 1996. Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J. Immunol. 156:4363-4368.
118. Berman, J. W., Guida, M. P., Warren, J., Amat, J., and Brosnan, C. F. 1996. Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J. Immunol. 156:3017-3023.
119. Simpson, J. E., Newcombe, J., Cuzner, M. L., and Woodroofe, M. N. 1998. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J. Neuroimmunol. 84:238-249.
120. McManus, C., Berman, J. W., Brett, F. M., Staunton, H., Farrell, M., and Brosnan, C. F. 1998. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J. Neuroimmunol. 86:20-29.
121. Diab, A., Abdalla, H., Li, H. L., Shi, F. D., Zhu, J., Hojberg, B., Lindquist, L., Wretlind, B., Bakhiet, M., and Link, H. 1999. Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1alpha attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis. Infect. Immun. 67:2590-2601.
122. Van Der Voorn, P., Tekstra, J., Beelen, R. H., Tensen, C. P., Van Der Valk, P., and De Groot, C. J. 1999. Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. Am. J. Pathol. 154:45-51.
123. Che, X., Ye, W., Panga, L., Wu, D. C., and Yang, G. Y. 2001. Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice. Brain Res. 902:171-177.
124. Weiss, J. M., Downie, S. A., Lyman, W. D., and Berman, J. W. 1998. Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier. J. Immunol. 161:6896-6903.
125. Miyagishi, R., Kikuchi, S., Takayama, C., Inoue, Y., and Tashiro, K. 1997. Identification of cell types producing RANTES, MIP-1-alpha and MIP-1-beta in rat experimental autoimmune encephalomyelitis by in situ hybridization. J. Neuroimmunol. 77:17-26.
126. Boven, L. A., Montagne, L., Nottet, H. S. L. M., and De Groot, C. I. A. 2000. Macrophage inflammatory protein-1 alpha (MIP-1 alpha), MIP-1 beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions. Clin. Exp. Immunol. 122:257-263.
127. Hurwitz, A. A., Lyman, W. D., and Berman, J. W. 1995. Tumor necrosis factor alpha and transforming growth factor beta upregulate astrocyte expression of monocyte chemoattractant protein-1. J. Neuroimmunol. 57:193-198.
128. Hayashi, M., Luo, Y., Laning, J., Strieter, R. M., and Dorf, M. E. 1995. Production and function of monocyte chemoattractant protein-1 and other beta-chemokines in murine glial cells. J. Neuroimmunol. 60:143-150.
129. Barnes, D. A., Huston, M., Holmes, R., Benveniste, E. N., Yong, V. W., Scholz, P., and Perez, H. D. 1996. Induction of RANTES expression by astrocytes and astrocytoma cell lines. J. Neuroimmunol. 71:207-214.
130. Conant, K., Garzino-Demo, A., Nath, A., Mcarthur, J. C., Halliday, W., Power, C., Gallo, R. C., and Major, E. O. 1998. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. USA 95:3117-3121.
131. Johnstone, M., Gearing, A. J. H., and Miller, K. M. 1999. A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced. J. Neuroimmunol. 93:182-193.
132. McManus, C. M., Weidenheim, K., Woodman, S. E., Nunez, J., Hesselgesser, J., Nath, A., and Berman, J. W. 2000. Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am. J. Pathol. 156:1441-1453.
133. Rah, J. C., Kim, H. S., Kim, S. S., Bach, J. H., Kim, Y. S., Park, C. H., Seo, J. H., Jeong, S. J., and Suh, Y. H. 2001. Effects of carboxyl-terminal fragment of Alzheimer's amyloid precursor protein and amyloid beta-peptide on the production of cytokines and nitric oxide in glial cells. FASEB J. 15:1463-1465.
134. Li, Q. Q. and Bever, C. T. 2001. Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcription. Neurochem. Res. 26:125-133.
135. Smits, H. A., Rijsmus, A., van Loon, J. H., Wat, J. W., Verhoef, J., Boven, L. A., and Nottet, H. S. 2002. Amyloid-beta-induced chemokine production in primary human macrophages and astrocytes. J. Neuroimmunol. 127:160-168.
136. Panenka, W., Jijon, H., Herx, L. M., Armstrong, J. N., Feighan, D., Wei, T., Yong, V. W., Ransohoff, R. M., and MacVicar, B. A. 2001. P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J. Neurosci. 21:7135-7142.
137. Andjelkovic, A. V., Song, L., Dzenko, K. A., Cong, H., and Pachter, J. S. 2002. Functional expression of CCR2 by human fetal astrocytes. J. Neurosci. Res. 70:219-231.
138. Banisadr, G., Queraud-Lesaux, F., Boutterin, M. C., Pelaprat, D., Zalc, B., Rostene, W., Haour, F., and Parsadaniantz, S. M. 2002. Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J. Neurochem. 81:257-269.
139. Jee, Y., Yoon, W. K., Okura, Y., Tanuma, N., and Matsumoto, Y. 2002. Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats. J. Neuroimmunol. 128:49-57.
140. Eugenin, E. A., D'Aversa, T. G., Lopez, L., Calderon, T. M., and Berman, J. W. 2003. MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J. Neurochem. 85:1299-1311.
141. Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., and Husemann, J. 2003. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat. Med. 9:453-457.
142. Dorf, M. E., Berman, M. A., Tanabe, S., Heesen, M., and Luo, Y. 2000. Astrocytes express functional chemokine receptors. J. Neuroimmunol. 111:109-121.
143. Cowell, R. M., Xu, H., Galasso, J. M., and Silverstein, F. S. 2002. Hypoxic-ischemic injury induces macrophage inflammatory protein-1alpha expression in immature rat brain. Stroke. 33:795-801.
144. Zuurman, M. W., Heeroma, J., Brouwer, N., Boddeke, H. W., and Biber, K. 2003. LPS-induced expression of a novel chemokine receptor (L-CCR) in mouse glial cells in vitro and in vivo. Glia 41:327-336.
145. Ghirnikar, R. S., Lee, Y. L., He, T. R., and Eng, L. F. 1996. Chemokine expression in rat stab wound brain injury. J. Neurosci. Res. 46:727-733.
146. Xia, M. Q., Qin, S. X., Wu, L. J., Mackay, C. R., and Hyman, B. T. 1998. Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains. Am. J. Pathol. 153:31-37.
147. Ambrosini, E., Columba-Cabezas, S., Serafini, B., Muscella, A., and Aloisi, F. 2003. Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro. Glia 41:290-300.
148. Serafini, B., Columba-Cabezas, S., Di Rosa, F., and Aloisi, F. 2000. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am. J. Pathol. 157:1991-2002.
149. Dieu-Nosjean, M. C., Massacrier, C., Homey, B., Vanbervliet, B., Pin, J. J., Vicari, A., Lebecque, S., Dezutter-Dambuyant, C., Schmitt, D., Zlotnik, A., and Caux, C. 2000. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J. Exp. Med. 192:705-718.
150. Streit, W. J. 2002. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40:133-139.
151. Aloisi, F. 2001. Immune function of microglia. Glia 36:165-179.
152. Nguyen, M. D., Julien, J. P., and Rivest, S. 2002. Innate immunity: the missing link in neuroprotection and neurodegeneration?. Nat. Rev. Neurosci. 3:216-227.
153. Ehrlich, L. C., Hu, S., Sheng, W. S., Sutton, R. L., Rockswold, G. L., Peterson, P. K., and Chao, C. C. 1998. Cytokine regulation of human microglial cell IL-8 production. J. Immunol. 160:1944-1948.
154. Hu, S., Chao, C. C., Ehrlich, L. C., Sheng, W. S., Sutton, R. L., Rockswold, G. L., and Peterson, P. K. 1999. Inhibition of microglial cell RANTES production by IL-10 and TGF-beta. J. Leukoc. Biol. 65:815-821.
155. Delgado, M., Jonakait, G. M., and Ganea, D. 2002. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia. Glia 39:148-161.
156. Moller, T., Hanisch, U. K., and Ransom, B. R. 2000. Thrombin-induced activation of cultured rodent microglia. J. Neurochem. 75:1539-1547.
157. Hausler, K. G., Prinz, M., Nolte, C., Weber, J. R., Schumann, R. R., Kettenmann, H., and Hanisch, U. K. 2002. Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopolysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages. Eur. J. Neurosci. 16:2113-2122.
158. Lipovsky, M. M., Gekker, G., Hu, S., Ehrlich, L. C., Hoepelman, A. I., and Peterson, P. K. 1998. Cryptococcal glucuronoxylomannan induces interleukin (IL)-8 production by human microglia but inhibits neutrophil migration toward IL-8. J. Infect. Dis. 177:260-263.
159. Lee, Y. B., Nagai, A., and Kim, S. U. 2002. Cytokines, chemokines, and cytokine receptors in human microglia. J. Neurosci. Res. 69:94-103.
160. Boddeke, E. W., Meigel, I., Frentzel, S., Biber, K., Renn, L. Q., and Gebicke-Harter, P. 1999. Functional expression of the fractalkine (CX3C) receptor and its regulation by lipopolysaccharide in rat microglia. Eur. J. Pharmacol. 374:309-313.
161. Tarozzo, G., Campanella, M., Ghiani, M., Bulfone, A., and Beltramo, M. 2002. Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia-reperfusion brain injury in the rat. Eur. J. Neurosci. 15:1663-1668.
162. Boehme, S. A., Lio, F. M., Maciejewski-Lenoir, D., Bacon, K. B., and Conlon, P. J. 2000. The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J. Immunol. 165:397-403.
163. Zujovic, V., Benavides, J., Vige, X., Carter, C., and Taupin, V. 2000. Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia 29:305-315.
164. Lokensgard, J. R., Hu, S., Sheng, W., vanOijen, M., Cox, D., Cheeran, M. C., and Peterson, P. K. 2001. Robust expression of TNP-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus. J. Neurovirol. 7:208-219.
165. D'Aversa, T. G., Weidenheim, K. M., and Berman, J. W. 2002. CD40-CD40L interactions induce chemokine expression by human microglia: implications for human immunodeficiency virus encephalitis and multiple sclerosis. Am. J. Pathol. 160:559-567.
166. Rappert, A., Biber, K., Nolte, C., Lipp, M., Schubel, A., Lu, B., Gerard, N. P., Gerard, C., Boddeke, H. W., and Kettenmann, H. 2002. Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl- current and chemotaxis in murine microglia. J. Immunol. 168:3221-3226.
167. McManus, C. M., Brosnan, C. F., and Berman, J. W. 1998. Cytokine induction of MIP-1 alpha and MIP-1 beta in human fetal microglia. J. Immunol. 160:1449-1455.
168. Si, Q., Cosenza, M., Zhao, M. L., Goldstein, H., and Lee, S. C. 2002. GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia. Glia 39:174-183.
169. Kim, M. O., Si, Q., Zhou, J. N., Pestell, R. G., Brosnan, C. F., Locker, J., and Lee, S. C. 2002. Interferon-beta activates multiple signaling cascades in primary human microglia. J. Neurochem. 81(6):1361-71.
170. Vago, L., Nebuloni, M., Bonetto, S., Pellegrinelli, A., Zerbi, P., Ferri, A., Lavri, E., Capra, M., Grassi, M. P., and Costanzi, G. 2001. Rantes distribution and cellular localization in the brain of HIV-infected patients. Clin. Neuropathol. 20:139-145.
171. Si, Q., Kim, M. O., Zhao, M. L., Landau, N. R., Goldstein, H., and Lee, S. 2002. Vpr- and Nef-dependent induction of RANTES/CCL5 in microglial cells. Virology. 301:342-353.
172. Ishizuka, K., Kimura, T., Igata-yi, R., Katsuragi, S., Takamatsu, J., and Miyakawa, T. 1997. Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatry Clin. Neurosci. 51:135-138.
173. Meda, L., Bernasconi, S., Bonaiuto, C., Sozzani, S., Zhou, D., Otvos, L., Jr., Mantovani, A., Rossi, F., and Cassatella, M. A. 1996. Beta-amyloid (25-35) peptide and IFN-gamma synergistically induce the production of the chemotactic cytokine MCP-1/JE in monocytes and microglial cells. J. Immunol. 157:1213-1218.
174. McManus, C. M., Liu, J. S., Hahn, M. T., Hua, L. L., Brosnan, C. F., Berman, J. W., and Lee, S. C. 2000. Differential induction of chemokines in human microglia by type I and II interferons. Glia 29:273-280.
175. Szczepanik, A. M., Funes, S., Petko, W., and Ringheim, G. E. 2001. IL-4, IL-10 and IL-13 modulate A beta(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J. Neuroimmunol. 113:49-62.
176. Columba-Cabezas, S., Serafini, B., Ambrosini, E., Sanchez, M., Penna, G., Adorini, L., and Aloisi, F. 2002. Induction of macrophage-derived chemokine/CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: implications for disease regulation. J. Neuroimmunol. 130:10-21.
177. Moser, B. and Loetscher, P. 2001. Lymphocyte traffic control by chemokines. Nat. Immunol. 2:123-128.
178. Hjelmstrom, P. 2001. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J. Leukoc. Biol. 69:331-339.
179. Columba-Cabezas, S., Serafini, B., Ambrosini, E., and Aloisi, F. 2003. Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation. Brain Pathol. 13:38-51.
180. He, J., Chen, Y., Farzan, M., Choe, H., Ohagen, A., Gartner, S., Busciglio, J., Yang, X., Hofmann, W., Newman, W., Mackay, C. R., Sodroski, J., and Gabuzda, D. 1997. CCR3 and CCR5 are coreceptors for HIV-1 infection of microglia. Nature. 385:645-649.
181. Ghorpade, A., Xia, M. Q., Hyman, B. T., Persidsky, Y., Nukuna, A., Bock, P., Che, M., Limoges, J., Gendelman, H. E., and Mackay, C. R. 1998. Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia. J. Virol. 72:3351-3361.
182. Albright, A. V., Shieh, J. T., Itoh, T., Lee, B., Pleasure, D., O'Connor, M. J., Doms, R. W., and Gonzalez-Scarano, F. 1999. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J. Virol. 73:205-213.
183. Xia, M. Q. and Hyman, B. T. 1999. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J. Neurovirol. 5:32-41.
184. van der Meer, P., Ulrich, A. M., Gonzalez-Scarano, F., and Lavi, E. 2000. Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia. Exp. Mol. Pathol. 69:192-201.
185. Trebst, C., Sorensen, T. L., Kivisakk, P., Cathcart, M. K., Hesselgesser, J., Horuk, R., Sellebjerg, F., Lassmann, H., and Ransohoff, R. M. 2001. CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am. J. Pathol. 159:1701-1710.
186. Simpson, J., Rezaie, P., Newcombe, J., Cuzner, M. L., Male, D., and Woodroofe, M. N. 2000. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue. J. Neuroimmunol. 108(1-2):192-200.
187. Cross, A. K. and Woodroofe, M. N. 1999. Chemokines induce migration and changes in actin polymerization in adult rat brain microglia and a human fetal microglial cell line in vitro. J. Neurosci. Res. 55:17-23.
188. Trebst, C., Staugaitis, S. M., Kivisakk, P., Mahad, D., Cathcart, M. K., Tucky, B., Wei, T., Rani, M. R., Horuk, R., Aldape, K. D., Pardo, C. A., Lucchinetti, C. F., Lassmann, H., and Ransohoff, R. M. 2003. CC chemokine receptor 8 in the central nervous system is associated with phagocytic macrophages. Am. J. Pathol. 162:427-438.
189. Abbadie, C., Lindia, J. A., Cumiskey, A. M., Peterson, L. B., Mudgett, J. S., Bayne, E. K., DeMartino, J. A., MacIntyre, D. E., and Forrest, M. J. 2003. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc. Natl. Acad. Sci. USA 100:7947-7952.
190. Tsai, H. H. and Miller, R. H. 2002. Glial cell migration directed by axon guidance cues. Trends Neurosci. 25:173-175; discussion 175-176.
191. Wu, Q., Miller, R. H., Ransohoff, R. M., Robinson, S., Bu, J., and Nishiyama, A. 2000. Elevated levels of the chemokine GRO-1 correlate with elevated oligodendrocyte progenitor proliferation in the jimpy mutant. J. Neurosci. 20:2609-2617.
192. Nguyen, D. and Stangel, M. 2001. Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells. Brain Res. Dev. Brain Res. 128:77-81.
193. Wingerchuk, D. M., Lucchinetti, C. F., and Noseworthy, J. H. 2001. Multiple sclerosis: current pathophysiological concepts. Lab. Invest. 81:263-281.
194. Miyagishi, R., Kikuchi, S., Fukazawa, T., and Tashiro, K. 1995. Macrophage inflammatory protein-1 alpha in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. J. Neurol. Sci. 129:223-227.
195. Franciotta, D., Martino, G., Zardini, E., Furlan, R., Bergamaschi, R., Andreoni, L., and Cosi, V. 2001. Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. J. Neuroimmunol. 115:192-198.
196. Sörensen, T. L., Sellebjerg, F., Jensen, C. V., Strieter, R. M., and Ransohoff, R. M. 2001. Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis. Eur. J. Neurol. 8:665-672.
197. Pashenkov, M., Soderstrom, M., and Link, H. 2003. Secondary lymphoid organ chemokines are elevated in the cerebrospinal fluid during central nervous system inflammation. J. Neuroimmunol. 135:154-160.
198. Giunti, D., Borsellino, G., Benelli, R., Marchese, M., Capello, E., Valle, M. T., Pedemonte, E., Noonan, D., Albini, A., Bernardi, G., Mancardi, G. L., Battistini, L., and Uccelli, A. 2003. Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. J. Leukoc. Biol. 73:584-590.
199. Luttichau, H. R., Clark-Lewis, I., Jensen, P. O., Moser, C., Gerstoft, J., and Schwartz, T. W. 2003. A highly selective CCR2 chemokine agonist encoded by human herpesvirus 6. J. Biol. Chem. 278:10928-10933.
200. Rottman, .T. B., Slavin, A. J., Silva, R., Weiner, H. L., Gerard, C. G., and Hancock, W. W. 2000. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent. Eur. J. Immunol. 30:2372-2377.
201. Fife, B. T., Huffnagle, G. B., Kuziel, W. A., and Karpus, W. J. 2000. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 192:899-905.
202. Izikson, L., Klein, R. S., Charo, I. F., Weiner, H. L., and Luster, A. D. 2000. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J. Exp. Med. 192:1075-1080.
203. Karpus, W. J. and Kennedy, K. J. 1997. MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J. Leukoc. Biol. 62:681-687.
204. Kennedy, K. J., Strieter, R. M., Kunkel, S. L., Lukacs, N. W., and Karpus, W. J. 1998. Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1alpha and monocyte chemotactic protein-1. J. Neuroimmunol. 92:98-108.
205. Fife, B. T., Kennedy, K. J., Paniagua, M. C., Lukacs, N. W., Kunkel, S. L., Luster, A. D., and Karpus, W. J. 2001. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 166:7617-7624.
206. McGeer, P. L. and McGeer, E. G. 2002. Local neuroinflammation and the progression of Alzheimer's disease. J. Neurovirol. 8:529-538.
207. Streit, W. J., Conde, J. R., and Harrison, J. K. 2001. Chemokines and Alzheimer's disease. Neurobiol. Aging 22:909-913.
208. Walker, D. G., Lue, L. F., and Beach, T. G. 2001. Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia. Neurobiol. Aging 22:957-966.
209. Galimberti, D., Schoonenboom, N., Scarpini, E., and Scheltens, P. 2003. Dutch-Italian Alzheimer Research Group. Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients. Ann. Neurol. 53:547-548.
210. Lipton, S. A. and Gendelman, H. E. 1995. Dementia associated with the acquired immunodeficiency syndrome. N. Eng. J. Med. 332:934-940.
211. Kaul, M., Garden, G. A., and Lipton, S. A. 2001. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988-994.
212. Schmidtmayerova, H., Nottet, H. S., Nuovo, G., Raabe, T., Flanagan, C. R., Dubrovsky, L., Gendelman, H. E., Cerami, A., Bukrinsky, M., and Sherry, B. 1996. Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. USA 93:700-704.
213. Sanders, V. J., Pittman, C. A., White, M. G., Wang, G., Wiley, C. A., and Achim, C. L. 1998. Chemokines and receptors in HIV encephalitis. AIDS 12:1021-1026.
214. Persidsky, Y., Ghorpade, A., Rasmussen, J., Limoges, J., Liu, X. J., Stins, M., Fiala, M., Way, D., Kim, K. S., Witte, M. H., Weinand, M., Carhart, L., and Gendelman, H. E. 1999. Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155:1599-1611.
215. Bonwetsch, R., Croul, S., Richardson, M. W., Lorenzana, C., Valle, L. D., Sverstiuk, A. E., Amini, S., Morgello, S., Khalili, K., and Rappaport, J. 1999. Role of HIV-1 Tat and CC chemokine MIP-1alpha in the pathogenesis of HIV associated central nervous system disorders. J. Neurovirol. 5:685-694.
216. Weiss, J. M., Nath, A., Major, E. O., and Berman, J. W. 1999. HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J. Immunol. 163:2953-2959.
217. Woodman, S. E., Benveniste, E. N., Nath, A., and Berman, J. W. 1999. Human immunodeficiency virus type 1 TAT protein induces adhesion molecule expression in astrocytes. J. Neurovirol. 5:678-684.
218. Kaul, M. and Lipton, S. A. 1999. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. U. S. A. 96:8212-8216.
219. Langford, D. and Masliah, E. 2001. Crosstalk between components of the blood brain barrier and cells of the CNS in microglial activation in AIDS. Brain Pathol. 11:306-312.
220. Tong, N., Perry, S. W., Zhang, Q., James, H. J., Guo, H., Brooks, A., Bal, H., Kinnear, S. A., Fine, S., Epstein, L. G., Dairaghi, D., Schall, T. J., Gendelman, H. E., Dewhurst, S., Sharer, L. R., and Gelbard, H. A. 2000. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J. Immunol. 164:1333-1339.
221. Brenneman, D. E., Hauser, J., Spong, C. Y., Phillips, T. M., Pert, C. B., and Ruff, M. 1999. VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death. Brain Res. 838:27-36.
222. Hesselgesser, J., Taub, D., Baskar, P., Greenberg, M., Hoxie, J., Kolson, D. L., and Horuk, R. 1998. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr. Biol. 8:595-598.
223. Matsumoto, T., Ikeda, K., Mukaida, N., Harada, A., Matsumoto, Y., Yamashita, J., and Matsushima, K. 1997. Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. Lab. Invest. 77:119-125.
224. Hughes, P. M., Allegrini, P. R., Rudin, M., Perry, V. H., Mir, A. K., and Wiessner, C. 2002. Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J. Cereb. Blood Flow. Metab. 22:308-317.
225. Wang, X., Ellison, J. A., Siren, A. L., Lysko, P. G., Yue, T. L., Barone, F. C., Shatzman, A., and Feuerstein, G. Z. 1998. Prolonged expression of interferon-inducible protein-10 in ischemic cortex after permanent occlusion of the middle cerebral artery in rat. J. Neurochem. 71:1194-1204.
226. Takami, S., Nishikawa, H., Minami, M., Nishiyori, A., Sato, M., Akaike, A., and Satoh, M. 1997. Induction of macrophage inflammatory protein MIP-1alpha mRNA on glial cells after focal cerebral ischemia in the rat. Neurosci. Lett. 227:173-176.
227. Soriano, S. G., Amaravadi, L. S., Wang, Y. F., Zhou, H., Yu, G. X., Tonra, J. R., Fairchild-Huntress, V., Fang, Q., Dunmore, J. H., Huszar, D., and Pan, Y. 2002. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J. Neuroimmunol. 125:59-65.
228. Popivanova, B. K., Koike, K., Tonchev, A. B., Ishida, Y., Kondo, T., Ogawa, S., Mukaida, N., Inoue, M., and Yamashima, T. 2003. Accumulation of microglial cells expressing ELR motif-positive CXC chemokines and their receptor CXCR2 in monkey hippocampus after ischemia-reperfusion. Brain Res. 970:195-204.
229. Geminder, H., Sagi-Assif, O., Goldberg, L., Meshel, T., Rechavi, G., Witz, I. P., and Ben-Baruch, A. 2001. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J. Immunol. 167:4747-4757.
230. Rempel, S. A., Dudas, S., Ge, S., and Gutierrez, J. A. 2000. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin. Cancer Res. 6:102-111.
231. Sehgal, A., Keener, C., Boynton, A. L., Warrick, J., and Murphy, G. P. 1998. CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells. J. Surg. Oncol. 69:99-104.
232. Oh, J. W., Drabik, K., Kutsch, O., Choi, C., Tousson, A., and Benveniste, E. N. 2001. CXC chemokine receptor 4 expression and function in human astroglioma cells. J. Immunol. 166:2695-2704.
233. Yamanaka, R., Tanaka, R., Yoshida, S., Saitoh, T., and Fujita, K. 1995. Growth inhibition of human glioma cells modulated by retrovirus gene transfection with antisense IL-8. J. Neurooncol. 25:59-65.
234. Desbaillets, I., Diserens, A. C., de Tribolet, N., Hamou, M. F. and Van Meir, E. G. 1999. Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene 18:1447-1456.
235. Yoshimura, T., Robinson, E. A., Tanaka, S., Appella, E., Kuratsu, J., and Leonard, E. J. 1989. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J. Exp. Med. 169:1449-1459.
236. Desbaillets, I., Tada, M., de Tribolet, N., Diserens, A. C., Hamou, M. F., and Van Meir, E. G. 1994. Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int. J. Cancer. 58:240-247.
237. Takeshima, H., Kuratsu, J., Takeya, M., Yoshimura, T., and Ushio, Y. 1994. Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. J. Neurosurg. 80:1056-1062.
238. Leung, S. Y., Wong, M. P., Chung, L. P., Chan, A. S., and Yuen, S. T. 1997. Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathol. (Berlin) 93:518-527.
239. Kielian, T., van Rooijen, N., and Hickey, W. F. 2002. MCP-1 expression in CNS-1 astrocytoma cells: implications for macrophage infiltration into tumors in vivo. J. Neurooncol. 56:1-12.